MILTUXIMAB
Live / Registered — Cancelled — Section 71 (as of 06 Dec 2024)
What this means for you
Registered since 22 May 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79219018
- Registration number
- 5472258
- Mark type
- Stylized text
- Filed
- 13 Sept 2017
- Published for opposition
- 06 Mar 2018
- Registered
- 22 May 2018
- Attorney of record
- David S. D'Ascenzo
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the diagnosis, treatment, or prevention of cancer, oncological disorders, auto-immune diseases, and inflammation diseases
Owner
Prosecution history
- 19 Feb 2026 — TOTAL INVALIDATION PROCESSED BY THE IB
- 30 Jan 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 30 Jan 2026 — INVALIDATION PROCESSED
- 06 Aug 2025 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 06 Dec 2024 — CANCELLED SECTION 71
- 30 Oct 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Sept 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 Sept 2018 — FINAL DISPOSITION PROCESSED
- 22 Aug 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB